Platelet-activating factor synthesis and response on pancreatic islet endothelial cells: Relevance for islet transplantation

Transplantation

Volumn 81, Issue 4, 2006, Pages 511-518

  Biancone, Luigi ^a   Cantaluppi, Vincenzo ^a   Romanazzi, Giuseppe Mauriello ^a   Russo, Simona ^a   Figliolini, Federico ^a   Beltramo, Silvia ^a   Scalabrino, Elisa ^a   Deregibus, Maria Chiara ^a   Romagnoli, Renata ^b   Franchello, Alessandro ^b   Salizzoni, Mauro ^b   Perin, Paolo Cavallo ^a   Ricordi, Camilla ^c   Segoloni, Giuseppe Paolo ^a   Camussi, Giovanni ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Liver Transplantation Center   (Italy)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

Endothelial cells; Inflammation; Islet transplantation; Pancreatic islets

Indexed keywords

BETA3 INTEGRIN; CD31 ANTIGEN; ENDOGLIN; LECTIN; MATRIGEL; THROMBIN;

ACCELERATION; ACETYLATION; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL IMMORTALIZATION; CELL MOTILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SCANNING ELECTRON MICROSCOPY; SIMIAN VIRUS 40; UPREGULATION;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL LINE; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLATELET ACTIVATING FACTOR; TRANSFECTION;

EID: 33644630005     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000200306.51689.f2     Document Type: Article

References (46)

1. Nyqvist D, Kohler M, Wahlstedt H, Berggren PO. Donor islet endothelial cells participate in formation of functional vessels within pancreatic islet grafts. Diabetes 2005; 54(8): 2287.
2. Zhang N, Richter A, Suriawinata J, et al. Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Diabetes 2004; 53(4): 963.
3. Lai Y, Schneider D, Kidszun A, et al. Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets. Transplantation 2005; 79(11): 1530.
4. Biancone L, Ricordi C. Pancreatic islet transplantation: an update. Cell Transplant 2002; 11(4): 309.
5. Pileggi A, Ricordi C, Alessiani M, Inverardi L. Factors influencing Islet of Langerhans graft function and monitoring. Clin Chim Acta 2001; 310(1): 3.
6. Johansson U, Olsson A, Gabrielsson S, Nilsson B, Korsgren O. Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. Biochem Biophys Res Commun 2003; 308(3): 474.
7. Matsuda T, Omori K, Vuong T, et al. Inhibition of p38 pathway suppresses human islet production of pro-inflammatory cytokines and improves islet graft function. Am J Transplant 2005; 5(3): 484.
8. Lou J, Triponez F, Oberholzer J, et al. Expression of alpha-1 proteinase inhibitor in human islet microvascular endothelial cells. Diabetes 1999; 48(9): 1773.
9. Linn T, Schneider K, Hammes HP, et al. Angiogenic capacity of endothelial cells in islets of Langerhans. FASEB J 2003; 17(8): 881.
10. Montrucchio G, Alloatti G, Camussi G. Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 2000; 80(4): 1669.
11. Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM. Platelet-activating factor and related lipid mediators. Annu Rev Biochem 2000; 69: 419.
12. Camussi G, Tetta C, Bussolino F, Baglioni C. Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions. J Exp Med 1990; 171(3): 913.
13. Camussi G, Mariano F, Biancone L, et al. Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide. J Immunol 1995; 155(1): 316.
14. Bussolino F, Arese M, Silvestro L, et al. Involvement of a serine protease in the synthesis of platelet-activating factor by endothelial cells stimulated by tumor necrosis factor-alpha or interleukin-1 alpha. Eur J Immunol 1994; 24(12): 3131.
15. Montrucchio G, Lupia E, Battaglia E, et al. Platelet-activating factor enhances VEGF-induced endothelial cell motility and neo-angiogenesis in a murine matrigel model. Arterioscler Thomb Vasc Biol 2000; 20(1): 80.
16. Montrucchio G, Lupia E, Battaglia E, et al. Tumor necrosis factor-α-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J Exp Med 1994; 180(1): 377.
17. Camussi G, Montrucchio G, Lupia E, et al. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages. J Immunol 1997; 158(3): 1302.
18. Biancone L, Cantaluppi V, Boccellino M, et al. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis. Am J Pathol 1999; 155(5): 1731.
19. Ko HM, Seo KH, Han SJ, et al. Nuclear factor kappaB dependency of platelet-activating factor-induced angiogenesis. Cancer Res 2002; 62(6): 1809.
20. Flickinger BD, Olson MS. Localization of the platelet-activating factor receptor to rat pancreatic microvascular endothelial cells. Am J Pathol 1999; 154(5): 1353.
21. Heuer HO, Casals-Stenzel J, Muacevic G, Weber KH. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet-activating factor. J Pharmacol Exp Ther 1990; 255(3): 962.
22. Litzkas P, Jha KK, Ozer HL. Efficient transfer of cloned DNA into human diploid cells: protoplast fusion in suspension. Mol Cell Biol 1984; 4(11): 2549.
23. Richards RG, Stiffanic M, Owen GR, et al. Immunogold labelling of fibroblast focal adhesion sites visualised in fixed material using scanning electron microscopy, and living, using internal reflection microscopy. Cell Biol Int 2001; 25(12): 1237.
24. Russo S, Bussolati B, Deambrosis I, et al. Platelet-activating factor mediates CD40-dependent angiogenesis and endothelial-smooth muscle cell interaction. J Immunol 2003; 171(10): 5489.
25. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37(8): 911.
26. Biancone L, Cantaluppi V, Duò D, Deregibus MC, et al. Role of L-selectin in the vascular homing of peripheral blood-derived endothelial progenitor cells. J Immunol 2004; 173(8): 5268.
27. Garlanda C, Parravicini C, Sironi M, et al. Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors. Proc Natl Acad Sci U S A 1994; 91(15): 7291.
28. Ozmen L, Ekdahl KN, Elgue G, et al. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes 2002; 51(6): 1779.
29. Olsson R, Carlsson PO. Better vascular engraftment and function in pancreatic islets transplanted without prior culture. Diabetologia 2005; 48(3): 469.
30. Barshes NR, Lee TC, Goodpastor SE, et al. Transaminitis after pancreatic islet transplantation. J Am Coll Surg 2005; 200(3): 353.
31. Hara M, Yin D, Dizon RF, et al. A mouse model for studying intrahepatic islet transplantation. Transplantation 2004; 78(4): 615.
32. Street CN, Lakey JR, Seeberger K, et al. Heterogenous expression of nestin in human pancreatic tissue precludes its use as an islet precursor marker. J Endocrinol 2004; 180(2): 213.
33. Treutelaar MK, Skidmore IM, Dias-Leme CL, et al. Nestin-lineage cells contribute to the microvasculature but not endocrine cells of the islet. Diabetes 2003; 52(10): 2503.
34. Montesano R, Pepper MS, Mohie-Steinlein U, et al. Increased proteolytic activity is responsible for the aberrant morphogenic behavior of endothelial cells expressing the middle T oncogene. Cell 1990; 62(3): 435.
35. Wagner EF, Risau W. Oncogenes in the study of endothelial cell growth and differentiation. Semin Cancer Biol 1994; 5(2): 137.
36. Hohenwarter O, Waltenberger A, Strutzenberger K, Katinger H. Human endothelial cell lines established by mutated forms of the simian virus 40 large T oncogene. J Biotechnol 1997; 54(2): 131.
37. Rundell K, Parakati R. The role of the SV40 ST antigen in cell growth promotion and transformation. Semin Cancer Biol 2001; 11(1): 5.
38. Brodsky JL, Pipas JM. Polyomavirus T antigens: molecular chaperones for multiprotein complexes. J Virol 1998; 72(7): 5329.
39. Johansson U, Elgue G, Nilsson B, Korsgren O. Composite islet-endothelial cell grafts: a novel approach to counteract innate immunity in islet transplantation. Am J Transplant 2005; 5(11): 2632.
40. Yang Y, Harvey SA, Gandhi CR. Kupffer cells are a major source of increased platelet activating factor in the CCl4-induced cirrhotic rat liver. J Hepatol 2003; 39(2): 200.
41. Moberg L, Korsgren O, Nilsson B. Neutrophilic granulocytes are the predominant cell type infiltrating pancreatic islets in contact with ABO-compatible blood. Clin Exp Immunol 2005; 142(1): 125.
42. Bennet W, Sundberg B, Groth CG, et al. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 1999; 48(10): 1907.
43. Berney T, Molano RD, Cattan P, et al. Endotoxin-mediated delayed islet graft function is associated with increased intra-islet cytokine production and islet cell apoptosis. Transplantation 2001; 71(1): 125.
44. Lupia E, Del Sorbo L, Bergerone S, et al. The membrane attack complex of complement contributes to plasmin-induced synthesis of platelet-activating factor by endothelial cells and neutrophils. Immunology 2003; 109(4): 557.
45. Camussi G, Mariano F, Biancone L, et al. Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide. J Immunol 1995; 155(1): 316.
46. Jin H, Varner J. Integrins: roles in cancer development and as treatment targets. Br J Cancer 2004; 90(3): 561.